iSERA Lifesciences opened at ₹143.90, in line with its previous close of ₹143.90. In the last trading session on 12 Nov 2026, the stock traded between ₹143.90 and ₹143.90, with an average traded price of ₹143.90. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in iSERA Lifesciences is now worth
₹ 17,33,735.00
Giving a profit of
₹ 17,23,735.00 (17237.35%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.00 (+0.00%)
Day High
₹143.90
Day Low
₹143.90
Day Open
₹143.90
Prev Close
₹143.90
Volume
175
Value Traded
₹0.00 Cr
1W Return
0.00%
1M Return
0.00%
3M Return
0.00%
6M Return
85.70%
1Y Return
1,569.37%
Market Cap (₹ Cr.)
354
PE Ratio
-1,798.80
PB Ratio
4.13
Dividend Yield
-
ROE
-8.82%
ROCE
4.21%
Book Value (₹)
34.88
Face Value (₹)
10.00
EPS (TTM)
-0.06
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
0.00%
6 Weeks
-
1 Month
0.00%
3 Months
0.00%
9 Months
380.15%
iSERA Lifesciences receives SEBI warning letter for disclosure failures
SEBI issued a warning letter to iSERA Lifesciences on November 6, 2026. Violations cited include failure to submit disclosures under Regulations 7(3), 13(3), and 47. Company states there is no impact on financial or operational activities.
TodayiSERA Lifesciences Q2FY27 net loss widens to ₹13.11 lakh
Net loss widened to ₹13.11 lakh in Q2FY27 versus ₹0.70 lakh profit in Q2FY26. Revenue from operations rose to ₹7.88 lakh from ₹1.00 lakh YoY. Total expenses surged to ₹20.39 lakh driven by employee benefits and admin costs. Cash and cash equivalents dropped to ₹3.55 lakh due to loan repayments.
8 days agoiSERA Lifesciences discloses preferential allotment to 31 allottees
iSERA Lifesciences disclosed preferential allotment to 31 allottees via share swap. Total equity shares outstanding rose from 84,08,972 to 2,45,91,772. Promoter Dhairyasheel Vasantrao Yadav acquired 4,50,500 shares; stake diluted to 6.37%. Promoter Archana Kakasaheb Lonkar acquired 4,95,000 shares; stake diluted to 4.86%. Equity capital increased from ₹8,40,89,720 to ₹24,59,17,720.
1mo agoiSERA Lifesciences declares voting results for 34th AGM held on September 29, 2026
iSERA Lifesciences declared voting results for its 34th AGM held on September 29, 2026. Both resolutions regarding FY26 financials and director reappointment passed with requisite majority. Total valid votes cast stood at 781,837, with zero votes against either resolution. Voting was conducted via remote e-voting and e-voting during the virtual AGM.
1mo agoiSERA Lifesciences schedules 34th AGM for September 29, 2026
iSERA Lifesciences schedules its 34th AGM for September 29, 2026. Agenda includes adoption of FY26 audited financial statements. Director Jitendra Prabhakar Nene seeks reappointment after retiring by rotation. Remote e-voting opens on September 26 with a cut-off date of September 22.
2mo agoiSERA Lifesciences utilizes ₹1.15 crore of rights issue proceeds in Q1FY27
iSERA Lifesciences Limited filed its Q1FY27 monitoring agency report for its ₹8.08 crore rights issue. The company utilized ₹1.15 crore during the quarter, primarily for working capital and office premises, with ₹6.26 crore remaining in fixed deposits and current accounts. No deviations from the offer document were reported.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹2,422.90 | -0.80% | ₹8,76,626.42 | 16.90 | -22.64% | |
| ₹1,142.70 | -0.74% | ₹4,63,734.22 | 15.10 | -26.36% | |
| ₹1,379.20 | -0.12% | ₹3,74,268.69 | 20.40 | -13.48% | |
| ₹196.27 | +0.04% | ₹1,94,410.26 | 14.70 | -19.96% | |
| ₹1,779.60 | +0.32% | ₹1,74,429.11 | 31.10 | +22.22% | |
| ₹4,296.50 | -0.17% | ₹1,27,443.35 | 24.50 | -27.10% | |
| ₹6,083.50 | +0.89% | ₹95,967.21 | 55.40 | -0.83% | |
| ₹2,066.10 | +1.58% | ₹91,523.70 | 42.90 | +13.04% | |
| ₹10,049.00 | +0.49% | ₹87,509.83 | 24.40 | +19.72% | |
| ₹2,441.10 | +1.29% | ₹46,612.81 | 23.00 | -13.61% | |
| ₹494.20 | -0.44% | ₹30,196.41 | 21.60 | -29.03% | |
| ₹3,870.90 | +0.23% | ₹24,117.93 | 35.90 | -28.16% |
An investment of ₹10,000 made 5 years ago in iSERA Lifesciences is now worth
₹ 17,33,735.00
Giving a profit of
₹ 17,23,735.00 (17237.35%)
Note: Past profits do not guarantee future returns.
